Oral Immunotherapy Reshapes Intestinal Immunosuppression via Metabolic Reprogramming to Enhance Systemic Anti‐Tumor Immunity

Abstract Tumor immunotherapy offers a new paradigm to treat cancer; however, the existing regimens are accompanied by the dilemma of insufficient therapeutic outcomes and off‐target adverse effects. The intestinal immune system contains a bulk of immune cells, which can be important contributors to...

Full description

Bibliographic Details
Main Authors: Xinran Cao, Yuan Xu, Chen Zhou, Jiawei Huo, Shenge Su, Lei Liu, Ziran Zhu, Lei Li, Wang Jia, Chunru Wang, Mingming Zhen
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202302910